Anna Suk-Fong Lok
University of Michigan
2 papers in the Anchorcite directory, published between 2003 and 2018, cited 8,967 times in total.
ORCID profileResearch topics
- Hepatitis C virus research · 2 papers
- Liver Disease Diagnosis and Treatment · 2 papers
- Liver Disease and Transplantation · 1 paper
- Hepatitis B Virus Studies · 1 paper
Frequent co-authors
- Chun Tao Wai · 1 paper
- Joel K. Greenson · 1 paper
- Robert J. Fontana · 1 paper
- John D. Kalbfleisch · 1 paper
- Jorge A. Marrero · 1 paper
- Hari S. Conjeevaram · 1 paper
- Norah A. Terrault · 1 paper
- Brian J. McMahon · 1 paper
Papers
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis CHepatology · 2003 · 4,492 citations
Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC) patients. However, most models for predicting liver fibrosis are complicated and separate formulas are needed to predict significant fibrosis and cirrhosis. The aim of our…
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology · 2018 · 4,475 citations
Potential conflict of interest: Dr. Hwang received grants from Merck and Gilead. Dr. Chang advises Arbutus. Dr. Lok received grants from Gilead and Bristol‐Myers Squibb. Dr. Jonas consults for Gilead and received grants from Bristol‐Myers Squibb and Roche. Dr. Brown…
Metadata from OpenAlex (CC0).